COLESEVELAM HYDROCHLORIDE POWDER FOR ORAL SUSPENSION VERSUS CHOLESTYRAMINE POWDER FOR ORAL SUSPENSION: COMPARISON OF ACCEPTABILITY AND TOLERABILITY

被引:5
作者
Bays, Harold E. [1 ]
Maki, Kevin C. [2 ]
Schmitz, Kathy [1 ]
机构
[1] Louisville Metab & Atherosclerosis Res Ctr, Louisville, KY 40213 USA
[2] Provident Clin Res, Glen Ellyn, IL USA
关键词
D O I
10.4158/EP10251.OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare tolerability of colesevelam hydrochloride powder versus a cholesterol-lowering equivalent dose of generic cholestyramine powder, each mixed in water, by means of the validated Bile Acid Sequestrant Acceptability (BASA) Scale. Methods: We conducted a randomized, single-blind, single-visit, single-site study, comparing doses of 2 different bile acid sequestrant powders for oral suspension that produce similar cholesterol lowering: colesevelam hydrochloride (3.75 g) and generic cholestyramine (12 g), each mixed in a transparent cup with tap water. Results: The study sample consisted of 42 participants-12 men and 30 women. The study subjects were non-Hispanic white (64%) or black (36%), with a mean age of 50 years and a mean body mass index of 32.2 kg/m(2). The components of the BASA Scale included taste, texture, appearance, and mixability. Colesevelam hydrochloride and cholestyramine did not differ significantly when assessed by both the unweighted and the weighted global BASA Scale. Although study participants indicated that the colorless or whitish colesevelam hydrochloride powder tasted better (P<.0001), they thought that the orange-colored cholestyramine had a more appealing appearance (P<.0001). Regarding the potential for taking the drug "for the rest of your life," 71.4% of study participants rated taste as "very important," and 11.9% rated appearance as "very important." Conclusion: Although study participants thought that the orange-colored generic cholestyramine powder had a better appearance, they also reported that colesevelam hydrochloride for oral suspension tasted better. A minority of study participants thought appearance was "very important"; a substantial majority thought taste was "very important" for potential long-term compliance.
引用
收藏
页码:218 / 225
页数:8
相关论文
共 19 条
[1]  
[Anonymous], DAILYMED
[2]  
[Anonymous], 2005, Blink: the power of thinking without thinking
[3]  
[Anonymous], 2010, WELC COL HYDR PACK I
[4]  
[Anonymous], 1990, MED REG CAUS NONC
[5]   Colesevelam HCl: a non-systemic lipid-altering drug [J].
Bays, H ;
Dujovne, C .
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (05) :779-790
[6]   The Bile Acid Sequestrant Acceptability Scale validation study [J].
Bays, H. E. ;
Maki, K. C. ;
Schmitz, K. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) :1393-1397
[7]  
Bays Harold E, 2007, Am J Ther, V14, P567, DOI 10.1097/MJT.0b013e31815a69fc
[8]   What's the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush? [J].
Bays, Harold E. ;
Ballantyne, Christie .
CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (06) :467-476
[9]  
Bays HE, 2007, 16 ANN M CLIN C AM A
[10]   BENEFICIAL-EFFECTS OF COMBINED COLESTIPOL-NIACIN THERAPY ON CORONARY ATHEROSCLEROSIS AND CORONARY VENOUS BYPASS GRAFTS [J].
BLANKENHORN, DH ;
NESSIM, SA ;
JOHNSON, RL ;
SANMARCO, ME ;
AZEN, SP ;
CASHINHEMPHILL, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (23) :3233-3240